| Patient | Geronimo |
|---|---|
| Date of birth | 1829-06-01 |
| Identifiers | MRN HR-NI016-SYN-TD; SSN (made up) 000-16-4729 |
| Document date | 1906-09-23 |
| Author | Roberta Whitehorse-Lindgren, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Eleven-week review: therapy, sertraline, drinking and falls. [S]
Geronimo returns eleven weeks after intake, with the interpreter. He has had eight sessions of cognitive processing therapy; he missed one when he had bronchitis three weeks ago, which has cleared without antibiotics. He has taken sertraline 25 mg for five weeks without nausea or dizziness. The sodium test planned for two to four weeks after starting was not done: it was not ordered at the sick visit, and today's test is the first. Nightmares come about twice a week and he sleeps five or six hours. He takes a single drink on one or two evenings a week and has had no heavy evening since the last visit. He has not fallen. [S]
| Element | Detail |
|---|---|
| Therapy | Eight of twelve sessions; one missed when ill |
| Sertraline | 25 mg for five weeks; no side effects |
| Sodium | 137 mmol/L |
| Drinking | One drink on one or two evenings a week |
| PCL-5 | 35 |
| System | Result | Finding |
|---|---|---|
| Psychiatric | Positive | Nightmares about twice a week; mood lighter; no thoughts of suicide |
| Respiratory | Negative | Cough gone |
| Neurological | Negative | No dizziness, confusion or headache |
| Gastrointestinal | Negative | No nausea, bleeding or black stools |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Thiamine 100 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1906-07-08 | active | S |
| Naltrexone 50 mg oral tablet, one tablet daily; carries a wallet card saying that naltrexone blocks opioid pain medicines | One tablet daily | Oral route | 1906-07-22 | active | S |
| Sertraline 25 mg oral tablet, one tablet each morning, raised to 50 mg after the sodium check | One tablet each morning | Oral route | 1906-08-19 to 1906-09-23 | completed | S |
| Sertraline 50 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 1906-09-23 | active | S |
| Acetaminophen 500 mg oral tablet, one or two tablets every 6 hours as needed for fever or aches, no more than 2,000 mg a day while his liver recovers | One or two tablets every 6 hours as needed, no more than 2,000 mg a day | Oral route | 1906-09-02 to 1906-09-16 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1906-09-23 | Body height | 173 | cm | S |
| 1906-09-23 | Body weight | 67.2 | kg | S |
| 1906-09-23 | Body mass index (BMI) [Ratio] | 22.5 | kg/m2 | S |
| 1906-09-23 | Systolic blood pressure | 130 | mm[Hg] | S |
| 1906-09-23 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1906-09-23 | Heart rate | 72 | /min | S |
| 1906-09-23 | Respiratory rate | 16 | /min | S |
| 1906-09-23 | Body temperature | 36.6 | Cel | S |
| 1906-09-23 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1906-09-23 | PTSD PCL-5 score [PCL-5] | 35 | {score} | S | ||
| 1906-09-23 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | {score} | S | ||
| 1906-09-23 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 1906-09-23 | Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 33 | U/L | 10-40 U/L | Normal | S |
| 1906-09-23 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 27 | U/L | 7-56 U/L | Normal | S |
| 1906-09-23 | Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma | 63 | U/L | 8-61 U/L | High | S |
| 1906-09-23 | Phosphatidylethanol [Mass/volume] in Blood | 41 | ng/mL | <=20 ng/mL | High | S |
Vital signs recorded on 1906-09-23; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 130/78 seated and 128/76 standing; pulse 72; weight 67.2 kg |
| Mental status | Calm and warm; speaks more of his horses and cattle; no thoughts of suicide or of harming anyone |
| Gait | Steady; Timed Up and Go 12 seconds |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Poor sleep for many years with nightmares and unwanted memories of past violence, worse over the past year; drinks at night to sleep; cause to be assessed | resolved | confirmed | G47.00 | S — Synthetic presenting problem anchored to the documented killing of his family and his years of war; resolved into the diagnosis of post-traumatic stress disorder at the consultation. Not a claim about his real sleep. |
| Post-traumatic stress disorder, chronic, confirmed with the CAPS-5 interview (PCL-5 56 at intake); prolonged grief disorder considered and criteria not met | active | confirmed | F43.12 | S — Synthetic modern diagnosis made at the consultation by current criteria; not a retrospective diagnosis of the historical person. |
| Alcohol use disorder, moderate (four DSM-5-TR criteria): drinking at night to sleep, more than intended, unable to cut down, and a fall walking home after drinking; AUDIT 19; liver tests show the pattern of heavy drinking | active | confirmed | F10.20 | S — Synthetic modern diagnosis anchored to his own statement that he was twice jailed for drinking whisky as a prisoner of war; not a claim about his real drinking. |
| A fall in the past month while walking home at night after drinking: bruised left hip, no fracture on examination; Timed Up and Go 13 seconds | active | confirmed | Z91.81 | S — Synthetic fall-risk finding; it is not his documented last fall, which is history after the episode. |
| Acute bronchitis with cough and low fever for six days, chest X-ray clear, oxygen saturation 95%; treated without antibiotics; resolved | resolved | confirmed | J20.9 | S — Synthetic self-limited illness; not a historical claim and not his documented last illness. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PTSD symptom severity (PCL-5) | Baseline, then every visit during treatment | Completed today | 35, from 56 |
| Self-management | Trauma-focused psychotherapy (cognitive processing therapy), sessions attended | Weekly for twelve sessions | Completed today | Eight of twelve sessions; one missed during bronchitis |
| Survey | Depressive symptoms (PHQ-9) | Baseline, then monthly during active treatment | Completed today | 7, from 10; item 9 scored 0 |
| Survey | Suicide-risk review, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; 988 card carried |
| Self-management | Drinking since the last visit, against his own goal | Every visit | Completed today | One drink on one or two evenings a week; no heavy evening |
| Laboratory | Liver tests (AST, ALT, GGT) on naltrexone | Before starting, at four to six weeks, then every three to six months | Completed today | AST 33, ALT 27, GGT 63 U/L |
| Laboratory | PEth, a blood marker of drinking over the past two to four weeks | At baseline and every one to three months during treatment, with consent | Completed today | 41 ng/mL, from 236 |
| Medication safety | Naltrexone safety: opioid use, nausea, wallet card | Every visit | Completed today | No opioid use; he declined a codeine cough syrup during the bronchitis |
| Medication safety | SSRI safety: sodium, bleeding, falls and side effects | Sodium within the first month in older adults; review at each dose change | Deferred | The sodium check due two to four weeks after starting sertraline was missed: it was not ordered at the sick visit two weeks after the start, the one visit in that window. Done today at five weeks: 137 mmol/L, so no harm resulted, and he had no symptoms of low sodium. Corrective action: a laboratory-only visit is booked two weeks after any future SSRI dose change, and the clinic's SSRI order set now prompts the sodium check |
| Medication safety | Prazosin for nightmares | When nightmares persist despite first-line treatment | Not indicated | Nightmares falling with therapy and sertraline; not needed now |
| Examination | Falls and gait (Timed Up and Go), orthostatic blood pressure | At intake and every visit after a fall | Completed today | Timed Up and Go 12 seconds; standing pressure 128/76; no falls |
| Self-management | Traditional healing alongside clinic care, at his choice | Every visit | Completed today | His choice; nothing asked |
Goal progress:
Guideline basis: VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults (2017); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); The Healthcare Professional's Core Resource on Alcohol (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Special General Memorandum 94-08: Statement of Policy for the Traditional Cultural Advocacy Program (1994); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024)
Follow-up: Wellness visit in two weeks. Sixteen-week review in five weeks with PEth, liver tests, PCL-5, PHQ-9 and AUDIT. Call the clinic or 988 at any hour. Next scheduled visit 1906-10-07: initial annual wellness visit. [S]